Gabriella Fredman1, Lone Skov1, Matthias Mann2,3, Beatrice Dyring-Andersen1,2,4. 1. Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. 2. Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark. 3. Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. 4. Leo Foundation Skin Immunology Research Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: The skin is the largest organ in the human body and serves as a multilayered protective shield from the environment as well as a sensor and thermal regulator. However, despite its importance, many details about skin structure and function at the molecular level remain incompletely understood. Recent advances in liquid chromatography tandem mass spectrometry (LC-MS/MS) proteomics have enabled the quantification and characterization of the proteomes of a number of clinical samples, including normal and diseased skin. SUMMARY: Here, we review the current state of the art in proteomic analysis of the skin. We provide a brief overview of the technique and skin sample collection methodologies as well as a number of recent examples to illustrate the utility of this strategy for advancing a broader understanding of the pathology of diseases as well as new therapeutic options. KEY MESSAGES: Proteomic studies of healthy skin and skin diseases can identify potential molecular biomarkers for improved diagnosis and patient stratification as well as potential targets for drug development. Collectively, efforts such as the Human Skinatlas offer improved opportunities for enhancing clinical practice and patient outcomes.
BACKGROUND: The skin is the largest organ in the human body and serves as a multilayered protective shield from the environment as well as a sensor and thermal regulator. However, despite its importance, many details about skin structure and function at the molecular level remain incompletely understood. Recent advances in liquid chromatography tandem mass spectrometry (LC-MS/MS) proteomics have enabled the quantification and characterization of the proteomes of a number of clinical samples, including normal and diseased skin. SUMMARY: Here, we review the current state of the art in proteomic analysis of the skin. We provide a brief overview of the technique and skin sample collection methodologies as well as a number of recent examples to illustrate the utility of this strategy for advancing a broader understanding of the pathology of diseases as well as new therapeutic options. KEY MESSAGES: Proteomic studies of healthy skin and skin diseases can identify potential molecular biomarkers for improved diagnosis and patient stratification as well as potential targets for drug development. Collectively, efforts such as the Human Skinatlas offer improved opportunities for enhancing clinical practice and patient outcomes.
Authors: N Macdonald; M Cumberbatch; M Singh; J G Moggs; G Orphanides; R J Dearman; C E M Griffiths; I Kimber Journal: Clin Exp Dermatol Date: 2006-05 Impact factor: 3.470
Authors: Paul Dowling; Benvon Moran; Edel McAuley; Paula Meleady; Michael Henry; Martin Clynes; Mairin McMenamin; Niamh Leonard; Mary Monks; Bairbre Wynne; Patrick Ormond; Annemarie Larkin Journal: Oncol Lett Date: 2016-09-07 Impact factor: 2.967
Authors: Beatrice Dyring-Andersen; Marianne Bengtson Løvendorf; Fabian Coscia; Alberto Santos; Line Bruun Pilgaard Møller; Ana R Colaço; Lili Niu; Michael Bzorek; Sophia Doll; Jørgen Lock Andersen; Rachael A Clark; Lone Skov; Marcel B M Teunissen; Matthias Mann Journal: Nat Commun Date: 2020-11-05 Impact factor: 14.919
Authors: Leyla A Akh; Mohammad O Ishak; Jennifer F Harris; Trevor G Glaros; Zachary J Sasiene; Phillip M Mach; Laura M Lilley; Ethan M McBride Journal: Cell Mol Life Sci Date: 2022-07-01 Impact factor: 9.207
Authors: Nicola Luigi Bragazzi; Charlie Bridgewood; Abdulla Watad; Giovanni Damiani; Jude Dzevela Kong; Dennis McGonagle Journal: Front Immunol Date: 2022-03-10 Impact factor: 7.561